MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report released on Tuesday. The brokerage issued a hold rating on the stock. Separately, Stifel Nicolaus lowered their price target on MEI Pharma from $10.00 to $9.00 and set a hold rating for the company in a report on Wednesday, September […]

Leave a Reply

Your email address will not be published.

Previous post Chicago Bulls guard Ayo Dosunmu receives NBA’s Bob Lanier award for community involvement
Next post Urban Outfitters (NASDAQ:URBN) Upgraded to “Buy” by